Group 1 - Beijing has launched its first public welfare medical insurance for newborns with rare diseases, providing health protection for the public [1] - The insurance is developed by the Capital Airport Economic Zone Management Committee, PICC Beijing Branch, and Beijing Life Insurance, covering 14 overseas special drugs and 8 domestic special drugs [1] - The initiative aims to enhance the accessibility and affordability of rare disease treatments through a combination of government guidance, enterprise underwriting, and social participation [1] Group 2 - By the end of 2023, relevant authorities approved the establishment of a rare disease drug guarantee pilot zone in the Tianzhu Comprehensive Bonded Zone, optimizing mechanisms and processes [2] - A total of 26 clinically needed imported drugs, including those for rare diseases, have been approved, benefiting over 4,900 patients [2] - From January to August 2025, the value of imported rare disease drugs exceeded 15.523 billion yuan [2]